Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of γirradiation

Abstract

Several novel pyrazole (11–18) and pyri-midine (19–23) derivatives were synthesized starting from different sulfonamides and different active methylenes The synthesized compounds were characterized by elemental analysis, IR, ¹H-NMR and mass spectral data. The obtained compounds were screened as antitumor agents against human tumor cell line. Some of the tested compounds were equipotent while the others were more potent than doxorubicin (CAS 25316-40-9). The synergistic effect with g-radiation was also studied.

Key word

γ-Irradiation - Pyrazole derivative - Pyrimidine derivative - Sulfonamides, antitumor activity

• Reference

• 1 Ghorab MM, Ismail ZH, Abdel-Gawad SM, Abdel-Aziem A. Antimicrobial activity of amino acids, imidazole and sulfon-amide derivatives of pyrazolo[3,4-d]pyrimidine. Het. Chem. 2004; 15 (1) 57-62
• 2 Özmen ÜÖ, Olgun G. Synthesis, characterization and antibacterial activity of new sulfonyl hydrazone derivatives and their nickel(II) complexes. Spectrochim Acta Part A Mol Biom Spectr. 2008; 70 (3) 641-5
• 3 Gawin R, De Clercq E, Naesens L, Stawinska MK. Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure. Bioorg Med Chem. 2008; 16 (18) 8379-89
• 4 Zhao Z, Wolkenberg SE, Lu M, Munshi V, Moyer G, Feng M et al. Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorg Med Chem Lett. 2008; 18 (2) 554-9
• 5 Ezabadi IR, Camoutsis C, Zoumpoulakis P, Geronikaki A, Sokovic M, Glamocilija J et al. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conforma-tional studies. Bioorg Med Chem. 2008; 16 (3) 1150-61
• 6 Saíz-Urra L, González MP, Collado IG, Hernández-Galán R. Quantitative structure–activity relationship studies for the prediction of antifungal activity of N-arylbenzenesulfon-amides against Botrytis cinerea. J Mol Graph Mod. 2007; 25 (5) 680-90
• 7 Anjaneyulu R, Anjaneyulu K, Couturier E, Malaisse WJ. Opposite effects of hypoglycemic and hyperglycemic sulfon-amides upon ionophore-mediated calcium transport. Biochem Pharmacol. 1980; 29 (13) 1879-82
• 8 Samols E, Weir GC, Ramseur R, Day JA, Patel YC. Modulation of pancreatic somatostatin by adrenergic and choli-nergic agonism and by hyper- and hypoglycemic sulfon-amides Metabolism. 1978; 27 (9) 1219-21
• 9 Jaiswal M, Khadikar PV, Supuran CT. Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Bioorg Med Chem Lett. 2004; 14 (22) 5661-6
• 10 Ruscin JM, Page RL, Scott J. Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: Evidence from a case report and a review of the literature. Am J Ger Pharmacol. 2006; 4 (4) 325-9
• 11 Ghorab MM, Abou El Ella DA, Noaman E, Heiba HI, Khalil AI. Computer-based ligand design and synthesis of some new sulfonamides bearing pyrrole or pyrrolopyrimidine moieties having potential antitumor and radioprotective activities. Phosphorous Sulfur Silicon. 2008; 183 (1) 90-104
• 12 Ghorab MM, Ragab FA, Noaman E, Heiba HI, El-Hossary E. Utility of 4-(5,5-dimethyl-3-oxo-cyclohex-1-enylamino)-benzensulfonamide in the synthesis of novel quinolines as possible anticancer and radioprotective agents. Arzneimittelforschung. 2007; 58 (1) 35-41
• 13 Ghorab MM, Ragab FA, Noaman E, Heiba HI, El-Hossary E. Synthesis of some novel quinolines and pyrimido[4,5-b]quinolines bearing as potential anticancer and radioprotective agents. Arzneimittelforschung. 2007; 57 (12) 795-803
• 14 Ghorab MM, Noaman E, Ismail MMF, Heiba HI, Ammar YA, Sayed MY. Novel antitumor and radioprotective sulfon-amides containing pyrrolo[2,3-d]pyrimidines. Arzneimittelforschung. 2006; 56 ((6)) 405-13
• 15 Ismail MMF, Ghorab MM, Noaman E, Ammar YA, Heiba HI, Sayed MY. Novel synthesis of pyrrolo[2,3-d]pyrimidines bearing sulfonamide moieties as potential antitumor and radioprotective agents. Arzneimittelforschung. 2006; 56 (4) 301-8
• 16 Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007; 15 (13) 4336-50
• 17 Garaj V, Puccetti L, Fasolis G, Winum J, Montero J, Scozzafava A et al. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties. Bioorg Med Chem Lett. 2004; 14 (21) 5427-33
• 18 Chou L, Huang L, Yang J, Lee F, Teng C, Kuo S. Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents. Bioorg Med Chem. 2007; 15 (4) 1732-40
• 19 Ciesielska E, Szulawska A, Studzian K, Ochocki J, Malinowska K, Kik K et al. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyra-zole ligands. J Inorg Biochem. 2006; 100 (10) 1579-85
• 20 Xie F, Zhao H, Zhao L, Lou L, Hu Y. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity. Bioorg Med Chem Lett. 2009; 19 (1) 1-16
• 21 El-Gaby MSA, Abdel-Hamid SG, Ghorab MM, El-Sayed SM. Synthesis and anticancer activity in vitro of some new pyrimidines Acta Pharm. 1999; 49: 149-58
• 22 Skehan P, Storeng R. New colorimetric cytotoxicity assay for anti-cancer drug screening. J Natl Cancer Inst. 1990; 82: 1107-12
• 23 Wang Z, Li W, Zhang H, Yang J, Qiu R, Wang X. Comparison of clonogenic assay with premature chromosome condensation assay in prediction of human cell radiosensitivity World J Gastroenterol. 2006; 12 (16) 2601-5